Cancer risk and tumour necrosis factor inhibitors in patients with inflammatory arthritis

Pharmacol Res. 2020 Aug:158:104507. doi: 10.1016/j.phrs.2019.104507. Epub 2019 Oct 31.

Authors

Francesca Marino¹, Valeria Nucera¹, Elisabetta Gerratana¹, Alessia Fiorenza¹, Donatella Sangari¹, Gianfranco Miceli¹, Ignazio Francesco Masala², Fabiola Atzeni³

Affiliations

¹ Rheumatology Unit, University of Messina, Messina, Italy.
² Trauma and Orthopedic Unit, Santissima Trinità Hospital, Cagliari, Italy.
³ Rheumatology Unit, University of Messina, Messina, Italy. Electronic address: atzenifabiola@hotmail.com.

PMID: 31678639
DOI: 10.1016/j.phrs.2019.104507

No abstract available

Keywords: Biological agents; Cancer; Rheumatoid arthritis; Spondyloarthritis.

Publication types

Review

MeSH terms

Anti-Inflammatory Agents / adverse effects*
Anti-Inflammatory Agents / therapeutic use*
Arthritis / complications*
Arthritis / drug therapy*
Arthritis, Rheumatoid / complications*
Arthritis, Rheumatoid / drug therapy*
Humans
Neoplasms / epidemiology*
Neoplasms / etiology*
Risk
Tumor Necrosis Factor Inhibitors / therapeutic use*
Tumor Necrosis Factor-alpha

Substances

Anti-Inflammatory Agents
Tumor Necrosis Factor Inhibitors
Tumor Necrosis Factor-alpha